Last Updated: September 24, 2026

Details for Patent: 5,478,578


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,478,578
Title:Powders for inhalation
Abstract:PCT No. PCT/EP92/02814 Sec. 371 Date Aug. 15, 1994 Sec. 102(e) Date Aug. 15, 1994 PCT Filed Dec. 12, 1992 PCT Pub. No. WO93/11746 PCT Pub. Date Jun. 24, 1993.In order to control and optimize the amount of inhalable active substance released when drugs are administered as inhalation powders, the invention calls for the use of auxiliaries consisting of mixtures of coarser particles (average particle size>20 mu m) and finer particles (average particle size<10 mu m).
Inventor(s):Klaus Arnold, Peter Grass, Adolf Knecht, Robert Roos, Gerhard Sluke, Herbet Thieme, Joachim Wenzel
Assignee: Boehringer Ingelheim GmbH
Application Number:US08/244,737
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 5,478,578

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,478,578

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany41 40 689.3Dec 10, 1991
PCT Information
PCT FiledDecember 12, 1992PCT Application Number:PCT/EP92/02814
PCT Publication Date:June 24, 1993PCT Publication Number: WO93/11746

International Family Members for US Patent 5,478,578

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 164060 ⤷  Start Trial
Australia 3085492 ⤷  Start Trial
Australia 670555 ⤷  Start Trial
Canada 2125685 ⤷  Start Trial
Germany 4140689 ⤷  Start Trial
Germany 59209244 ⤷  Start Trial
Denmark 0663815 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.